No treatment-related effects with aryloxyalkanoate dioxygenase-12 in three 28-day mouse toxicity studies

    loading  Checking for direct PDF access through Ovid


The aryloxyalkanoate dioxygenase-12 (AAD-12) protein is expressed in genetically modified soybean events DAS-68416-4 and DAS-444ϕ6-6. Expression of the AAD-12 protein in soybeans confers tolerance to the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) providing an additional herbicide choice to farmers. This enzyme acts by catalyzing the degradation of 2,4-D into herbicidally inactive metabolites. To meet evolving interpretation of regulations in the European Union, three separate 28-day repeat-dose oral mouse studies were conducted at increasing doses of up to 1100 mg AAD-12 protein/kg bw/day. No treatment-related effects were seen in any of these three studies.HighlightsThe AAD-12 protein is expressed in genetically modified soybeans.AAD-12 confers herbicidal tolerance to 2,4-D.No treatment-related effects of AAD-12 protein in three 28-day mouse studies.

    loading  Loading Related Articles